Abbreviations: ASD, atrial septal defect; ICS, intercostal space; RIJ, right internal jugular vein; SVC, superior vena cava; RA, right atrium.
Bold script represents our preferred site/approach.
Shann and Melnitchouk
149
non-ECG-gated CT angiography
of the abdomen and pel-
vis in all patients undergoing minimally invasive mitral
valve repair. This allows us to screen the majority of
patients for coronary artery disease, evaluate the presence
of mitral annular calcification, rule out significant aortoil-
iac atherosclerosis, and assess aortal dimensions with 1
noninvasive test. Coronary angiography is then obtained
as an adjunctive screening test in older patients and those
with significant risk factors. Similarly, the group from
Cleveland Clinic advocates for CT angiography in all
patients undergoing minimally invasive robotic mitral
valve surgery because aortoiliac atherosclerosis and/or
mitral annular calcification has changed their operative
strategy in 20% of screened patients, albeit the majority of
that quintile’s patients were older and had other risk
factors.
38
The axillary artery can be used for arterial access in situ-
ations where the femoral approach is prohibitive because of
atherosclerosis or tortuosity. In addition, the axillary has
also been used for minimal access ascending and aortic
arch surgery through an upper hemisternotomy.
39
There are arterial cannulas that have been designed pri-
marily for minimally invasive cardiac valve surgery.
ThruPort Systems (Edwards Lifesciences; Irvine, CA) is a
system of minimally invasive cannulas (http://www.
edwards.com/Products/MIVS/Pages/MIVS.aspx) that are
designed to facilitate minimally invasive intracardiac pro-
cedures. ThruPort commonly utilizes the EndoReturn fem-
oral artery cannula that is inserted under direct vision
using the Seldinger technique. For isolated mitral valve
procedures, the IntraClude catheter can also be used to
facilitate endovascular aortic cross-clamping, cardioplegia
delivery, and aortic root venting. The IntraClude is inserted
through a side arm of the EndoReturn cannula and
advanced into the ascending aorta under transesophageal
echocardiogram (TEE) guidance.
The ascending aorta can be cannulated for minimally
invasive procedures with a variety of cannulas that have
been designed for ascending aortic cannulation. At our
center, we use a small caliber (7 mm) wire-reinforced dif-
fusion cannula. There are other arterial cannulas, such as
the Fem-Flex II (Edwards Lifesciences, Irvine, CA) and
Bio-Medicus (Medtronic, Minneapolis, MN), that are
designed for percutaneous femoral arterial cannulation
using a modified Seldinger technique. Tables 2 and 3 pro-
vide reference values for the arterial cannula options we
utilize.
In addition, the axillary artery can be cannulated utiliz-
ing the graft interposition technique and sewing a 8-mm
Gore-Tex graft end-to-side to the artery and then inserting
a ¼″ × 3/8″ connector into the graft. The graft is secured to
the connector with heavy sutures or umbilical tape. In
summary, we recommend the following strategies for arte-
rial cannulation during minimally invasive procedures:
•
• surgical procedure and patient disease characteris-
tics will dictate the site of arterial cannulation and
•
• when considering femoral arterial cannulation, CT
angiography should be utilized to screen patients at
risk for aortoiliac atherosclerosis.
Dostları ilə paylaş: